RUNX2 and breast carcinoma: In addition, CaSki cells are derived from the metastatic site, and the results of RUNX2 expression agree with those reported in the metastatic cell lines MDA-MB-231, Sum49 and Sum59 of breast cancer, which have high expression of RUNX2 [48,49].